Ravi Salgia to Antibodies, Neutralizing
This is a "connection" page, showing publications Ravi Salgia has written about Antibodies, Neutralizing.
Connection Strength
0.030
-
Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy. Mol Cancer. 2014 Oct 24; 13:242.
Score: 0.030